KeJingBio
公司核心技术涵盖高通量虚拟筛选、生物信息学与计算生物学的融合应用，以及生命科学领域的智能化解决方案。通过AI算法从海量数据库中精准识别潜在分子，公司极大地提升了筛选效率，为新药研发和基础生物研究提供了革命性支持。结合生物信息学和计算生物学的先进方法，公司开发的创新技术不仅推动了生物科技领域的智能化转型，也为生命科学领域的研究与应用开辟了全新路径。此外，我们通过提供智能化生命科学解决方案，为生物医药、医学诊断、大健康产业的客户提供技术支持，帮助他们加速实现从研究到应用的全流程转化。 公司汇聚了一批在生物技术和人工智能领域具备深厚学术造诣和丰富实践经验的高端人才，通过跨学科协作，持续攻克技术难题，拓展科技应用边界。我们专注于计算机辅助高通量虚拟筛选技术，结合生物信息学、计算生物学和人工智能的先进方法，开发出精准、高效的分子筛选解决方案。这些技术已广泛应用于生命科学研究、医学诊断、新药研发等领域，为行业发展注入了强劲动力。 合肥科晶生物技术有限公司成立于2022年，是一家致力于AI与生物技术深度融合的高新技术企业。自成立以来，公司凭借卓越的研发实力和开创性的技术创新，在生物科技与人工智能领域
Basic Information
- Category: business
- Website: https://KJfold.com
Documented Facts
- Email: wangshuang@biorpa.com (No linked source recorded for this statement.)
Evidence and Sources
- KeJingBio — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about KeJingBio.
- Canonical profile: https://brandsource.ai/brands/kejingbio
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/kejingbio/json-ld
- Citation profile API: https://brandsource.ai/api/brands/kejingbio/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Structured profile (59/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
KeJingBio is listed in business on BrandSource.AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
Known data gaps
- Needs a specific, non-thin summary
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.